{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:58:39Z","timestamp":1787007519952,"version":"build-2736575974"},"reference-count":80,"publisher":"Informa UK Limited","issue":"7","funder":[{"DOI":"10.13039\/100008322","name":"CSL Behring","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100008322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Hematology"],"published-print":{"date-parts":[[2019,7,3]]},"DOI":"10.1080\/17474086.2019.1624520","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T04:35:11Z","timestamp":1559622911000},"page":"525-540","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":4,"title":["Prothrombin complex concentrate for vitamin K antagonist reversal in acute bleeding settings: efficacy and safety"],"prefix":"10.1080","volume":"12","author":[{"given":"Helmut","family":"Ostermann","sequence":"first","affiliation":[{"name":",","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"von Heymann","sequence":"additional","affiliation":[{"name":",","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,6,17]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08753.x"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2016-309832"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2305"},{"key":"e_1_3_5_6_1","unstructured":"NICE. NICE implementation collaborative consensus. 2017. [cited 2018 Sept]. Available from: https:\/\/www.nice.org.uk\/guidance\/cg180\/resources\/nic-consensus-statement-on-the-use-of-noacs-243733501"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2292"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2010.09.008"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eur126"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03070.x"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-2295"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(99)00079-1"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1080\/02688690050175265"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13054-016-1265-x"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-017-1506-0"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH16-04-0266"},{"issue":"7","key":"e_1_3_5_17_1","first-page":"CD010555","article-title":"Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients","author":"Johansen M","year":"2015","unstructured":"Johansen M, Wikkelso A, Lunde J, et al. Prothrombin complex concentrate for reversal of vitamin K antagonist treatment in bleeding and non-bleeding patients. Cochrane Database Syst Rev. 2015;(7):CD010555.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.002283"},{"key":"e_1_3_5_18_2","unstructured":"1234\u20131243."},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(16)00110-1"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2014.02.016"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-014-9972-0"},{"issue":"6","key":"e_1_3_5_22_1","first-page":"1145","article-title":"Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists","volume":"110","author":"de Lecinana MA","year":"2013","unstructured":"de Lecinana MA, Huertas N, Egido JA, et al. Questionable reversal of anticoagulation in the therapeutic management of cerebral haemorrhage associated with vitamin K antagonists. Thromb Haemost. 2013;110(6):1145\u20131151.","journal-title":"Thromb Haemost"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2014.05.001"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0049-3848(02)00402-4"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.090464"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1423-0410.2010.01339.x"},{"issue":"3","key":"e_1_3_5_27_1","first-page":"877","article-title":"Comparison between prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP) for the urgent reversal of warfarin in patients with mechanical heart valves in a tertiary care cardiac center","volume":"14","author":"Fariborz Farsad B","year":"2015","unstructured":"Fariborz Farsad B, Golpira R, Najafi H, et al. Comparison between prothrombin complex concentrate (PCC) and fresh frozen plasma (FFP) for the urgent reversal of warfarin in patients with mechanical heart valves in a tertiary care cardiac center. Iran J Pharm Res. 2015;14(3):877\u2013885.","journal-title":"Iran J Pharm Res"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61685-8"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jemermed.2015.07.024"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-015-1330-3"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2015.07.023"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2017.12.011"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-017-0374-y"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.4103\/IJCIIS.IJCIIS_40_17"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajem.2017.01.049"},{"key":"e_1_3_5_36_1","unstructured":"NovoNordisk. NovoSeven US prescribing information. 2016."},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2007.09.002"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1186\/1749-7922-9-27"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wneu.2010.06.030"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24384"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1385\/NCC:4:3:206"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2014.12.026"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2016.05.019"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2011.04.017"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc11669"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2012.05.029"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.112.652065"},{"issue":"2","key":"e_1_3_5_48_1","first-page":"148","article-title":"Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage","volume":"9","author":"Imberti D","year":"2011","unstructured":"Imberti D, Barillari G, Biasioli C, et al. Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage. Blood Transfus. 2011;9(2):148\u2013155.","journal-title":"Blood Transfus"},{"key":"e_1_3_5_49_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-012-0817-4"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja11.10797"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1159\/000448815"},{"key":"e_1_3_5_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2011.07.024"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2008.02904.x"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2007.02.009"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/1865-1380-6-14"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc13843"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1177\/1076029612450772"},{"issue":"6","key":"e_1_3_5_58_1","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s12185-017-2311-4","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study","volume":"106","author":"Kushimoto S","year":"2017","unstructured":"Kushimoto S, Fukuoka T, Kimura A, et al. Efficacy and safety of a 4-factor prothrombin complex concentrate for rapid vitamin K antagonist reversal in Japanese patients presenting with major bleeding or requiring urgent surgical or invasive procedures: a prospective, open-label, single-arm phase 3b study. Int J Hematol. 2017;106(6):777\u2013786.","journal-title":"Int J Hematol"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.0007-1048.2001.03295.x"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-79-4-485"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.108.520668"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2006.07.034"},{"key":"e_1_3_5_63_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.65.10.1320"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1186\/cc11923"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2014.08.024"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.063701"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2006.01815.x"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.thromres.2004.09.002"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2008.01859.x"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2015.04.036"},{"key":"e_1_3_5_71_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-05-0367"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13191"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1111\/acem.12911"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-018-0940-4"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-015-0508-5"},{"key":"e_1_3_5_76_1","first-page":"885066618800657","article-title":"Evaluation of the use of low-dose 4-factor prothrombin complex concentrate in the reversal of direct oral anticoagulants in bleeding patients","author":"Allison TA","year":"2018","unstructured":"Allison TA, Lin PJ, Gass JA, et al. Evaluation of the use of low-dose 4-factor prothrombin complex concentrate in the reversal of direct oral anticoagulants in bleeding patients. J Intensive Care Med. 2018;885066618800657.","journal-title":"J Intensive Care Med"},{"key":"e_1_3_5_77_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcrc.2018.08.031"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40560-018-0303-y"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12959-017-0158-9"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/rth2.12089"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2018024893"}],"container-title":["Expert Review of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17474086.2019.1624520","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T09:55:49Z","timestamp":1770890149000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17474086.2019.1624520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,17]]},"references-count":80,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7,3]]}},"alternative-id":["10.1080\/17474086.2019.1624520"],"URL":"https:\/\/doi.org\/10.1080\/17474086.2019.1624520","relation":{},"ISSN":["1747-4086","1747-4094"],"issn-type":[{"value":"1747-4086","type":"print"},{"value":"1747-4094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,17]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierr20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-03-27","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-06-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}